BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $426,859 | $167,645 | $141,561 | -$64,080 |
| Dep. & Amort. | $96,426 | $104,386 | $101,969 | $108,039 |
| Deferred Tax | $56,096 | -$44,981 | -$52,087 | -$15,608 |
| Stock-Based Comp. | $201,571 | $0 | $0 | $197,263 |
| Change in WC | -$216,396 | -$336,539 | -$96,383 | $66,034 |
| Other Non-Cash | $8,285 | $268,748 | $80,842 | $12,888 |
| Operating Cash Flow | $572,841 | $159,259 | $175,902 | $304,536 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$85,424 | -$107,611 | -$131,540 | -$95,578 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$410,250 | -$868,496 | -$611,809 | -$937,143 |
| Inv. Sales/Matur. | $633,018 | $864,863 | $619,995 | $691,049 |
| Other Inv. Act. | -$853 | $0 | $103,325 | -$24,641 |
| Investing Cash Flow | $136,491 | -$111,244 | -$20,029 | -$366,313 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$494,987 | -$2,286 | -$2,605 | -$3,039 |
| Stock Issued | $0 | $69,353 | $69,333 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$31,460 | -$85,794 | -$85,378 | $2,991 |
| Financing Cash Flow | -$526,447 | -$18,727 | -$18,650 | -$48 |
| Forex Effect | $4,830 | $1,308 | $32 | -$57 |
| Net Chg. in Cash | $187,715 | $30,596 | $137,255 | -$61,882 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $755,127 | $724,531 | $587,276 | $649,158 |
| End Cash | $942,842 | $755,127 | $724,531 | $587,276 |
| Free Cash Flow | $475,423 | $62,568 | $54,943 | $185,311 |